Abstract
Caner is a leading cause of death worldwide which requires a multidisciplinary treatment approach. Safety and efficacy of many of the modern therapies have been well established but still use of complementary and alternative medicines (CAM) are on rise among cancer patients. CAM decision making process is complex which is affected by many social and disease related variables. Prevalence based studies regarding CAM use reported a wide range of variation in percentage use of CAM among cancer patients which could be due to the way different studies defined CAM in their studies. Understanding CAM use decision making is crucial as it is highly individualized and revolves around several issues which can benefit patients and their care givers in treatment success.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
